Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous glucose monitoring in frail elderly patients with type 2 diabetes using metformin with or without sulfonylureas
NL-OMON42250Recruiting
- Sponsor
- Isala
- Start
- Dec 2014
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of metformin, gliclazide and glimepiride in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Isala. Started Dec 2014; status: recruiting.
02
Drugs
metformingliclazideglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON42250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42250.